(Q46437590)

22 December 2017

title

Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test (English)

1 reference

22 December 2017

author

Sulev Koks

5

1 reference

22 December 2017

Toshimitsu Matsui

7

1 reference

22 December 2017

Sirli Raud

1

object named as

Sirli Raud

1 reference

22 December 2017

2

Jürgen Innos

1 reference

22 December 2017

8

Eero Vasar

1 reference

22 December 2017

Urho Abramov

3

1 reference

22 December 2017

Ain Reimets

4

1 reference

22 December 2017

Andres Soosaar

6

1 reference

22 December 2017

publication date

1 September 2005

1 reference

22 December 2017

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

22 December 2017

volume

181

1 reference

22 December 2017

page(s)

347-357

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-2255-x

exact match

0 references

cites work

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-2255-X

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-2255-X

Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas

21 January 2018

1 reference

12 December 2020

A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice

1 reference

12 December 2020

A new benzodiazepine pharmacology.

1 reference

12 December 2020

Anxiolytic effects of CCK-B antagonists

1 reference

12 December 2020

Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour.

1 reference

12 December 2020

Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice

1 reference

12 December 2020

Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: differential cortical expression of cholecystokinin2 receptors

1 reference

12 December 2020

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

12 December 2020

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.

1 reference

12 December 2020

Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety

1 reference

12 December 2020

CCK in animal and human research on anxiety

1 reference

12 December 2020

Molecular and neuronal substrate for the selective attenuation of anxiety.

1 reference

12 December 2020

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

12 December 2020

Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices

1 reference

12 December 2020

Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background

1 reference

12 December 2020

Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation.

1 reference

12 December 2020

1 reference

12 December 2020

Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice

1 reference

12 December 2020

Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine

1 reference

12 December 2020

Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons.

1 reference

12 December 2020

Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit.

1 reference

12 December 2020

The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.

1 reference

12 December 2020

Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

1 reference

12 December 2020

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

1 reference

12 December 2020

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

12 December 2020

Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice.

1 reference

12 December 2020

International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors

1 reference

12 December 2020

Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens.

1 reference

12 December 2020

Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.

1 reference

12 December 2020

GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus.

1 reference

12 December 2020

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.

1 reference

12 December 2020

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations

1 reference

12 December 2020

Neuropeptide-containing neurons of the cerebral cortex are also GABAergic

1 reference

12 December 2020

Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus

1 reference

12 December 2020

Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat.

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.

1 reference

12 December 2020

Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies.

1 reference

12 December 2020

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues.

1 reference

12 December 2020

Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning.

1 reference

12 December 2020

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

12 December 2020

The functional neuroanatomy of emotion and affective style.

1 reference

12 December 2020

Reduced anxious behavior in mice lacking the CCK2 receptor gene.

1 reference

12 December 2020

Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.

1 reference

12 December 2020

Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive

1 reference

12 December 2020

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

1 reference

12 December 2020

10.1007/S00213-005-2255-X

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15830228

1 reference

22 December 2017